featured
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Diabetes Technol. Ther. 2022 Nov 01;24(11)814-823, GP Forlenza, AL Carlson, RJ Galindo, DF Kruger, CJ Levy, JB McGill, G Umpierrez, G AleppoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.